packageSutimlimab

sutimlimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sutimlimab is a monoclonal antibody that inhibits complement and is used to treat haemolysis in cold agglutinin disease, a form of autoimmune haemolytic anaemia. It is approved and authorised in the European Union, though it remains a newer, specialised treatment.

Summary written by glm-5.3-flash from Wikidata Q60785670 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sutimlimab
ATC codes:L04AJ04
DrugBank:DB14996
Wikidata:Q60785670
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown